Sarclisa

PARIS, July 10, 2026 Sanofi announced that the U.S. Food and Drug Administration (FDA) has approved Sarclisa Escena® (isatuximab-irfc)...

PARIS | June 19, 2026 Sanofi announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved the...

PARIS, France, June 8, 2026 Sanofi announced that the European Commission has approved Sarclisa® (isatuximab) subcutaneous (SC) for the...

Paris, France | March 27, 2026 CHMP Recommends Innovative Subcutaneous Formulation Sanofi has achieved a major regulatory milestone as...